Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Recurrence × Radiation × Clear all

Phase

Phase 2 2 Phase 1 2 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Carcinoma 2 Stomach Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Perivascular Epithelioid Cell Neoplasms 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Neurofibrosarcoma 1 Nerve Sheath Neoplasms 1 Mucositis 1 Mouth Neoplasms 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Histiocytoma, Angiomatoid Fibrous 1 Head and Neck Neoplasms 1 Granuloma, Plasma Cell 1 Gliosarcoma 1 Fibrosarcoma 1 Extensive Stage Lung Small Cell Carcinoma 1 Esophageal Squamous Cell Carcinoma 1 Dermatofibrosarcoma 1 Chondrosarcoma, Mesenchymal 1

Interventions

Temozolomide 3 Etoposide 3 pembrolizumab 2 Lomustine 2 Haloperidol 2 Gemcitabine 2 Cyclosporine 2 vocimagene amiretrorepvec 1 trofosfamide 1 ruxolitinib 1 regorafenib 1 peginterferon alfa-2b 1 osimertinib 1 interferon gamma-1b 1 interferon gamma, Cys(-3), Tyr(-2), Cys(-1)- 1 imetelstat 1 glumetinib 1 etoposide phosphate 1 eculizumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carbon-11 acetate 1 auricularum 1 aldesleukin 1 Thiotepa 1 Sirolimus 1 Rituximab 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03970447 2025-09-09

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡